Pharmaceutical company Regenerex strikes a licensing deal with Holista Colltech
Regenerex Pharma and Holista Colltech Collaborate on Advanced Wound Care Solutions
Regenerex Pharma, Inc., a leading innovator in advanced wound closure systems for chronic wounds, has partnered with Holista Colltech Ltd., a globally recognized producer of high-purity ovine collagen. This collaboration aims to bring cutting-edge, biologically advanced wound care solutions to both U.S. and international markets.
Regenerex Pharma is incorporating ovine nano-collagen, a product of Holista Colltech, into its wound healing protocols. The ultra-small molecular size of ovine nano-collagen provides an ideal biomaterial scaffold to support and accelerate cellular growth, which is particularly advantageous for chronic wounds requiring deeper regeneration.
The integration of ovine nano-collagen offers significant benefits. It enhances deep tissue regeneration through superior scaffolding and cellular proliferation. Regenerex claims a healing rate of up to 95% for chronic wounds within 90 days, attributable to the enhanced scaffolding that supports cell proliferation and tissue repair.
The collaboration also presents safety and regulatory advantages. Ovine collagen sourced from disease-free Australian sheep avoids risks linked to traditional bovine collagen, such as mad cow disease (BSE). This reduces regulatory hurdles and aligns with strict safety standards required by authorities like the FDA.
Moreover, unlike bovine or porcine collagen, ovine collagen is more acceptable in diverse cultural and religious contexts, allowing Regenerex to expand into Asia-Pacific, Middle Eastern, and European markets where such considerations limit other collagen sources.
The collaboration also supports Regenerex's push for innovative, biologically advanced wound care systems and improves competitiveness in the growing $25 billion chronic wound care market globally.
Regenerex Pharma's contact information is as follows:
- Company phone: 877-761-RGPX (7479)
- Investor Relations phone: (305) 927-5191
- Email: [email protected]
- Website: regenerexpharmainc.com
Regenerex Pharma has entered into a licensing agreement with Holista Colltech Ltd. for ovine collagen. However, Regenerex Pharma has not undertaken any obligation to update or revise forward-looking statements.
Additional risks and uncertainties that may cause actual results to differ can be found in reports filed with the Securities and Exchange Commission. It is important to note that this press release contains forward-looking statements subject to various risks and uncertainties.
Holista Colltech Ltd.'s collagen is derived from ethically sourced, disease-free Australian sheep, ensuring a high-purity product with strong ethical sourcing credentials. Regenerex Pharma's mission is to provide solutions in human health crises by solving chronic wound closure and reducing amputations.
[1] Regenerex Pharma, Inc. (2021). Press Release: Regenerex Pharma Announces Collaboration with Holista Colltech Ltd. Retrieved from https://www.regenerexpharmainc.com/news-and-media/press-releases/detail/7/regenerex-pharma-announces-collaboration-with-holista-colltech-ltd
[2] Regenerex Pharma, Inc. (2021). Press Release: Regenerex Pharma Presents Data Demonstrating the Efficacy of Ovine Nano-Collagen in Wound Healing at the 2021 Wounds Australia National Conference. Retrieved from https://www.regenerexpharmainc.com/news-and-media/press-releases/detail/8/regenerex-pharma-presents-data-demonstrating-the-efficacy-of-ovine-nano-collagen-in-wound-healing-at-the-2021-wounds-australia-national-conference
[3] Regenerex Pharma, Inc. (2021). Press Release: Regenerex Pharma Announces Collaboration with Holista Colltech Ltd. Retrieved from https://www.regenerexpharmainc.com/news-and-media/press-releases/detail/7/regenerex-pharma-announces-collaboration-with-holista-colltech-ltd
[4] Regenerex Pharma, Inc. (2021). Press Release: Regenerex Pharma Presents Data Demonstrating the Efficacy of Ovine Nano-Collagen in Wound Healing at the 2021 Wounds Australia National Conference. Retrieved from https://www.regenerexpharmainc.com/news-and-media/press-releases/detail/8/regenerex-pharma-presents-data-demonstrating-the-efficacy-of-ovine-nano-collagen-in-wound-healing-at-the-2021-wounds-australia-national-conference
[1] This collaboration between Regenerex Pharma and Holista Colltech, focusing on advanced wound care solutions, could potentially have positive implications for health-and-wellness, particularly for individuals suffering from chronic wounds.
[2] The integration of ovine nano-collagen, a product of Holista Colltech, into Regenerex Pharma's healing protocols, offers significant improvements in performance, as it enhances deep tissue regeneration through superior scaffolding and cellular proliferation.
[3] The security of this innovative wound care solution is enhanced due to the use of ovine collagen sourced from disease-free Australian sheep, which avoids risks associated with traditional collagen sources like mad cow disease (BSE), thereby aligning with strict safety standards and regulatory requirements.
